Physician profile
Vivian Ting
NPI 1982662045
$2,269.62
in general payments reported to CMS, 2019-2025
11 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $427 · 2020: $122 · 2021: $952 · 2022: $328 · 2023: $101 · 2024: $199 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $439.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $1,022.78 | 2019-2022 | |
| Mentor Worldwide LLC | $363.32 | 2019-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Allergan, INC. | $191.40 | 2019-2021 | |
| Integra Lifesciences Corporation | $143.70 | 2021 | |
| Abbvie INC. | $142.74 | 2023-2024 | Natrelle Saline-Filled Breast Implants, Alloderm |
| Coopersurgical, INC. | $115.00 | 2025 | Onetrac Lx |
| Musculoskeletal Transplant Foundation INC. | $108.64 | 2024 | |
| Stryker Corporation | $86.60 | 2019 | |
| Motiva USA, LLC | $57.26 | 2024-2025 | |
| Galderma Laboratories, L.P. | $21.35 | 2020 | |
| Polarityte, INC. | $16.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivian Ting listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.